Allopregnanolone - La Jolla PharmaceuticalAlternative Names: LJPC-0712; Niemann-Pick type C disease (NP-C) therapy - La Jolla Pharmaceutical; Pregnanolone - La Jolla Pharmaceutical
Latest Information Update: 18 Jul 2013
At a glance
- Originator La Jolla Pharmaceutical Company
- Class Anxiolytics; General anaesthetics; Hypnosedatives; Pregnanes; Small molecules
- Mechanism of Action GABA A receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Niemann-Pick disease type C